肺隐球菌病临床研究进展
关键词:
隐球菌；肺疾病；诊断学；治疗学摘要
隐球菌被世界卫生组织列为真菌重点病原体之首，全球范围内对人类健康构成严重威胁。肺隐球菌病主要由呼吸道传播，可扩散至脑、血液等部位，隐球菌脑膜炎是主要致死并发症。近年来，肺隐球菌病发病率不断上升，因症状和影像学表现不典型，常被误诊为肺炎、肺癌、结核等，导致高病死率。本文综述其诊疗进展，目的是加深临床医生对该病的认识，并利于早期诊断及治疗, 提高医学水平。
参考
[1]DENNING D W. Global incidence and mortality of severe fungal disease[J]. Lancet, Infect. Dis. 2024, 24(7): e428–e438.
[2]NGAMSKULRUNGROJ P, CHANG Y, SIONOV E, et al. The primary target organ of cryptococcus gattii is different from that of cryptococcus neoformans in a murine model[J]. mBio, 2012, 3(3): e00103-12.
[3]MATSUMOTO Y, AZAMI S, SHIGA H, et al. Induction of signal transduction pathways related to the pathogenicity of cryptococcus neoformans in the host environment[J]. Drug Discov. Ther., 2019, 13(4): 177–182.
[4]MATSUMOTO Y, AZAMI S, SHIGA H, et al. Induction of signal transduction pathwaysrelated to the pathogenicity of cryptococcus neoformans in the host environment[J]. Drug Discov. Ther., 2019, 13(4): 177–182.
[5]KRONSTADJ,SAIKIA S, NIELSON E D, et al. Adaptation of cryptococcus neoformans to mammalian hosts: integrated regulation of metabolism and virulence[J]. Eukaryot. Cell, 2012, 11(2): 109–118.
[6]XUE P, SÁNCHEZ-LEÓN E, HU G, et al. The interplay between electron transport chain function and iron regulatory factors influences melanin formation in cryptococcus neoformans[J]. mSphere, 2024, 9(5): e0025024.
[ 7 ] P I A N A L T O K M , O S T K S , B R O W N H E , e t a l . Characterization of additional components of the environmental pHsensing complex in the pathogenic fungus cryptococcus neoformans[J]. J. Biol. Chem., 2018, 293(26): 9995–10008.
[8]BAKER R P, LIU A Z, CASADEVALL A. Cell wall melanin impedes growthof the cryptococcus neoformans polysaccharide capsule by sequestering calcium[J]. Proc. Natl. Acad. Sci. U. S. A., 2024, 121(38): e2412534121.
[9]UENO K, NAGAMORI A, HONKYU N O, et al. Cryptococcus neoformans requires the TVF1 gene for thermotolerance and virulence[J]. Med. Mycol., 2023, 61(10): myad101.
[10]TOPLIS B, BOSCH C, SCHWARTZ I S, et al. The virulence factor urease and its unexplored role in the metabolism of cryptococcus neoformans[J]. FEMS Yeast Res., 2020, 20(4): foaa031.
[11] 李平, 罗娟, 李晓莉, 等. 隐球菌免疫逃逸机制研究进展[J]. 中国真菌学杂志, 2024, 19(5): 519–524.
[12]ZARAGOZA O, CHRISMAN C J, CASTELLI M V, et al. Capsule enlargement in cryptococcus neoformans confers resistance to oxidative stress suggesting a mechanism for intracellular survival[J]. Cell. Microbiol., 2008, 10(10): 2043–2057.
[13]MCFADDEN D C, FRIES B C, WANG F, et al. Capsule structural heterogeneity and antigenic variation in cryptococcus neoformans[J]. Eukaryot. Cell, 2007, 6(8): 1464–1473.
[14]ME M, E D, A C, et al. Radial mass density, charge, and epitope distribution in the cryptococcus neoformans capsule[J/OL]. Eukaryot. Cell, 2007, 6(1).
[15]Anonymous. Cryptococcal titan cells: when yeast cells are all grown.up-PubMed[EB/OL]([no date])[2025-02-26].
[16]ARANGO-FRANCOCA,MIGAUDM,RAMÍREZ-SÁNCHEZ I C, et al. Anti-GM-CSF neutralizing autoantibodies in.colombian. patients.with.disseminated.cryptococcosis[J]. J Clin Immunol, 2023, 43(5): 921–932.
[17]CAMPUZANO A, CASTRO-LOPEZ N, MARTINEZ A J, et al. CARD9 is required for classical macrophage activation and the induction of protective immunity against pulmonary cryptococcosis[J]. mBio, 2020, 11(1): e03005-19.
[18]ZAVALA S, BADDLEY J W. Cryptococcosis[J]. Semin. Respir. Crit. Care Med., 2020, 41(1): 69–79.
[19] 刘文娟, 穆乃外尔·萨比尔, 贾鹏, 等. 肺隐球菌病在有无症状时的临床及CT 影像学特征分析[J]. 中国ct 和mri 杂志, 2025, 23(2): 83–85.
[20] 陈桂荣, 秦志强, 韦彩周, 等. 开展隐球菌荚膜抗原检测对肺隐球菌病诊疗的影响[J]. 内科, 2024, 19(4): 377–380.
[21]WANG H, YAN S, LIU Y, et al. Metagenomic next-generation sequencing assists in the diagnosis of cryptococcus pneumonia: case series and literature review[J]. Front. Public Health, 2022, 10: 971511.
[22] 刘家莉, 柯华, 陈维永, 等. 1 例氟康唑治疗肺隐球菌病患者的诊治经验[J]. 现代临床医学, 2024, 50(4): 270–271, 276.
[23]LOYSE A, BURRY J, COHN J, et al. Leave no one behind: response to new evidence and guidelines for the management of cryptococcal meningitis in low-income and middle-income countries[J]. Lancet, Infect. Dis., 2019, 19(4): e143–e147.
[24] 张露, 鲁雁秋, 刘丹, 等. 两性霉素B 联合泊沙康唑治疗艾滋病合并隐球菌性脑膜炎的有效性及安全性[J]. 中国药房,2024, 35(16): 2018–2022.
[25]GRIMSHAW A, PALASANTHIRAN P, HUYNH J, et al. Cryptococcal infections in children: retrospective study and review from Australia[J]. Future Microbiol., 2019, 14: 1531–1544.
